Stocks · Health care · Biological Products, (No Diagnostic Substances)

Century Therapeutics, Inc.

IPSC Clue Score63
United States Fiscal year ends December CIK 0001850119 Results filed 12 Aug 2026

What the insiders did Net buying

By person

14 insiders · 72 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Aktiengesellschaft Bayer
10% owner
$15.00M (1)
—
+$15.00M
12,675,838
$19.25M
—
Eli Casdin
Director
$15.00M (1)
—
+$15.00M
3,206,380
$4.87M
—
Versant Venture Capital VI, L.P. entity
10% owner
$2.00M (1)
$7.17M (1)
−$5.17M
12,166,109
$18.48M
+308.1%
Luis Borges
Chief Scientific Officer
—
$539.88K (3) scheduled
−$539.88K
256,535
$389.68K
—
Adrienne Farid
Chief Operations Officer
—
$297.10K (12) scheduled
−$297.10K
250,141
$379.96K
+237.0%
Gregory Russotti
See Remarks
—
$123.44K (18) scheduled
−$123.44K
601,971
$914.39K
+62.2%
Chad Cowan
Chief Scientific Officer
$49.25K (1)
$2.74K (1)
+$46.52K
1,175,322
$1.79M
+763.8%
Douglas Carr
SVP Finance & Operations
—
$40.16K (23)
−$40.16K
502,641
$763.51K
+170.9%
Brent Pfeiffenberger
President and CEO
$47.68K (2)
$59.96K (6)
−$12.28K
3,633,839
$5.52M
+26,137%
Daphne Quimi
Director
$7.66K (1)
—
+$7.66K
5,000
$7.59K
—
FUJIFILM Cellular Dynamics, Inc. entity
10% owner
—
—
—
6,955,207
$10.56M
+133.3%
Michael Craig Diem
Chief Financial Officer
—
—
—
253,533
$385.12K
+219.0%
Morgan Conn
Chief Finanical Officer
—
—
—
79,648
$120.99K
—
Hyam Levitsky
President of R&D
—
—
—
24,000
$36.46K
—

No percentages here. This company's share count has moved by a factor of 2.1 over the window, from 86,158,758 to 181,075,321 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.